Kenya may give the world the first vaccine to protect against gonorrhoea, which causes about 87 million infections annually.
Scientists at the Kenya Medical Research Institute (Kemri) and the University of Oxford, UK, plan to recruit 50 Kenyans, aged between 18 and 25 years into a six-month gonorrhoea vaccine trial.
The trials, initially planned to start in June this year, are currently in the final approval phase and will be carried out at the Kemri clinic in Mtwapa, Kilifi County.
Facts First
Unlock bold, fearless reporting, exclusive stories, investigations, and in-depth analysis with The Standard INSiDER subscription.
Already have an account? Login